ArticleBeilstein journal of nanotechnology2026
Optimization of NiMo alloy nanoparticles for catalytic dry reforming of methane.
Article in Beilstein journal of nanotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metallic Ni nanoparticles doped with Mo are recently developed highly active nanocatalysts for dry reforming of methane (DRM). However, the nature of interactions and co-existence of Ni and Mo, optimal Ni/Mo ratios, as well as the impact of synthetic methods on catalyst structure and activity, remain unclear. This study compares two different synthetic approaches, one-pot synthesis (OP) and post-modification (PM), to determine the optimal Ni/Mo ratio for catalytic performance. The OP method promotes the formation of NiMo nanoparticles under adequate reducing conditions, significantly enhancing DRM activity. In contrast, the PM method ensures precise Ni/Mo ratios but leads to the formation of large MoO
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.